CRDL Stock Price
Cardiol Therapeutics Inc.
CRDL stock price is $1.14 (-5.00% on the day), giving Cardiol Therapeutics Inc. a market cap of $135.79M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
CRDL Stock Overview
- Price
- $1.14
- Previous close
- $1.20
- Open
- $1.20
- Market cap
- $135.79M
- P/E ratio
- -4.0
- 52-week range
- $0.88 - $2.34
- 1-year price target
- $7.99
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NSC
- MarketXLS Rank
- 27
About Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRDL | $1.14 | -5.0% | 687.22K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cardiol Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW